Venture Philanthropy
Our mission is to accelerate life-changing solutions to cure, prevent and treat type 1 diabetes (T1D) through equity investments. This requires we take 100% concentration risk in drugs, diagnostics, platforms, devices and other health solutions with application to T1D.
Selfishly, I'd like to make a difference in my daughter's life, but my heartstrings have also been torn by children whose parents don't have the resources my wife and I do. By giving to the Fund we know we are making a difference for everyone with T1D.
What the Fund was good at doing was saying, ‘We’re going to try to fill gaps. We’re going to back some of the companies to help them demonstrate their investment potential. We’re going to back some at an earlier stage.
The team's ability to make decisions quickly from start to finish coupled with the broad net that has been cast on innovative, exiting and dynamic opportunities makes us proud to be a part of this thrilling effort.
For Donors
A philanthropic vehicle run as a venture capital fund.
The T1D Fund provides a unique vehicle for philanthropists interested in a high-impact, high-leverage opportunity.
Our sole focus is on raising and investing private capital for opportunities that will change the lives of those who live with, or at risk of developing, T1D.
Similar to limited partners in the commercial sector, donors to the T1D Fund engage with management and leadership, redefining the philanthropic experience and creating a differentiated donor experience.
All donors must contribute a minimum of $500,000 over four years. Donors do not receive distributions on gains as all returns are reinvested back into the Fund so that we can support the next generation of life-changing T1D therapies.
As a donor, you benefit from:
- 501(c)(3) donation, with associated tax benefits at the time of contribution for U.S. donors
- Local tax benefits for international donations
- Regular updates on investments, transparent quarterly reporting including webcasts, and face-to-face updates — just like a venture capital fund
- Full access to management and governance groups
- Option for donors to allow the Fund to give their names to CEOs as potential investors in target companies